Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?
Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?
1930-1932
Vorechovsky, I.
7245de2f-8c9b-4034-8935-9a451d9b682e
Jones, A.V.
daa5d0cf-4454-48c3-abb8-daf03aa21e8b
Cross, N.C.P.
f87650da-b908-4a34-b31b-d62c5f186fe4
September 2013
Vorechovsky, I.
7245de2f-8c9b-4034-8935-9a451d9b682e
Jones, A.V.
daa5d0cf-4454-48c3-abb8-daf03aa21e8b
Cross, N.C.P.
f87650da-b908-4a34-b31b-d62c5f186fe4
Vorechovsky, I., Jones, A.V. and Cross, N.C.P.
(2013)
Why do we see JAK2 exon 12 mutations in myeloproliferative neoplasms?
Leukemia, 27 (9), .
(doi:10.1038/leu.2013.85).
(PMID:23511126)
This record has no associated files available for download.
More information
Accepted/In Press date: 20 March 2013
Published date: September 2013
Organisations:
Human Development & Health
Identifiers
Local EPrints ID: 350830
URI: http://eprints.soton.ac.uk/id/eprint/350830
ISSN: 0887-6924
PURE UUID: 4bba40eb-0d3d-4d4d-b4ed-ed4a4252da5d
Catalogue record
Date deposited: 08 Apr 2013 13:56
Last modified: 15 Mar 2024 03:16
Export record
Altmetrics
Contributors
Author:
A.V. Jones
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics